Funder
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Carlsbergfondet
Lundbeckfonden
American Diabetes Association
Eli Lilly and Company
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference54 articles.
1. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes;Nauck;Diabetologia,1986
2. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006
3. Targeting the incretin/glucagon system with triagonists to treat diabetes;Capozzi;Endocrine Rev,2018
4. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013
5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J. Clin. Endocrinol. Metab,1993
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献